Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Experimental Therapeutics

Effect of Parenteral Antibiotic Administration on Establishment of Intestinal Colonization by Candida glabrata in Adult Mice

Nicole J. Pultz, Usha Stiefel, Mahmoud Ghannoum, Marion S. Helfand, Curtis J. Donskey
Nicole J. Pultz
1Research Section
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Usha Stiefel
2Division of Infectious Diseases
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahmoud Ghannoum
3Center for Medical Mycology, Department of Dermatology, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marion S. Helfand
1Research Section
4Infectious Diseases Section, Louis Stokes Cleveland Veterans Affairs Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Curtis J. Donskey
1Research Section
4Infectious Diseases Section, Louis Stokes Cleveland Veterans Affairs Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: curtisd123@yahoo.com
DOI: 10.1128/AAC.49.1.438-440.2005
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We examined the effect of antibiotic treatment on establishment of intestinal colonization by Candida glabrata in adult mice. Subcutaneous ceftriaxone, piperacillin-tazobactam, clindamycin, and metronidazole promoted increased density of stool colonization, whereas cefepime, levofloxacin, and aztreonam did not. These findings suggest that antibiotics that inhibit intestinal anaerobes promote C. glabrata colonization.

The gastrointestinal tract is a primary site of colonization by Candida species and is frequently a source for hematogenous dissemination in cancer patients (1). Antibiotics play a crucial role in the pathogenesis of Candida infections by inhibiting competing indigenous microflora, thereby facilitating acquisition and overgrowth of Candida species in the gastrointestinal tract and at other sites (1). Several studies suggest that antibiotics that inhibit obligate anaerobes in the intestinal tract may be more likely to promote overgrowth of C. albicans than those that do not (1, 4, 5, 7, 8-11), but little data regarding the effect of antibiotics on colonization with other Candida species are available. We used a mouse model to test the hypothesis that antibiotics with potent activity against intestinal anaerobes (piperacillin-tazobactam, metronidazole, ceftriaxone, and clindamycin) promote overgrowth of Candida glabrata, whereas agents with minimal activity against anaerobes (cefepime, levofloxacin, and aztreonam) do not.

Four C. glabrata strains were used: ATCC 90030, MRL 191, A129, and A239. The fluconazole MICs for the strains were 32, 16, 0.5, and 4 μg/ml, respectively. The experimental protocol was approved by the Cleveland Veterans Affairs Medical Center's Animal Care Committee. Female CF1 mice (Harlan Sprague-Dawley, Indianapolis, Ind.) weighing 25 to 30 g were used. To prevent cross-contamination, mice were housed in individual cages with filter tops. An initial experiment (four mice per group) was performed to examine the ability of the four C. glabrata strains to colonize the intestinal tract. Mice were treated daily with subcutaneous normal saline (0.2 ml) or piperacillin-tazobactam (8 mg in 0.2 ml of normal saline) for 2 days before and 6 days after orogastric inoculation of 108 CFU of C. glabrata with a stainless steel feeding tube (Popper & Sons, New Hyde Park, N.Y.). Piperacillin-tazobactam was chosen for the initial experiment because we have previously demonstrated that it inhibits anaerobes, facultative gram-negative bacilli, and enterococci in the stool of mice (2). Fresh stool samples were collected at baseline and 1, 3, and 6 days after inoculation of C. glabrata. For quantification of C. glabrata, serially diluted stool samples were plated onto Sabouraud dextrose agar (Becton, Dickinson, and Company, Sparks, Md.) containing piperacillin-tazobactam (16 μg/ml) and incubated in room air at 37°C for 48 h. The lower limit of detection was ∼2 log10 CFU/g.

Strains A239 and ATCC 90030 were chosen to evaluate the effect of different antibiotics on establishment of colonization because they had the highest stool densities in the initial experiment. Mice received daily subcutaneous antibiotics or saline for 2 days before and 6 days after orogastric inoculation of 106 CFU of one of the C. glabrata strains. Antibiotics included piperacillin-tazobactam (8 mg/day), ceftriaxone (2.4 mg/day), cefepime (2.0 mg/day), levofloxacin (0.375 mg/day), aztreonam (3.0 mg/day), and metronidazole (4 mg/day); for the experiment with ATCC 90030, clindamycin (1.4 mg/day) was substituted for metronidazole because metronidazole caused significant soft-tissue irritation in the initial experiments. The antibiotic doses were equal to the total daily dose recommended for human adults (milligrams per kilogram of body weight) with the exception of that for metronidazole, which was given at approximately four times the usual dose because increased dosages are required to inhibit the anaerobic microflora of mice (2). Because cefepime, levofloxacin, and aztreonam did not promote overgrowth at the lower doses, higher human equivalent doses calculated by the technique of Freireich et al. (3) (cefepime, 24 mg/day; levofloxacin, 4.7 mg/day; aztreonam, 37.5 mg/day) were also administered for comparison in the experiments with strain A239. The density of C. glabrata was measured as described above. The densities of aerobic and facultative gram-negative bacilli and enterococci were measured by plating the samples onto MacConkey agar (Becton Dickinson and Company) and Enterococcosel agar (Becton Dickinson and Company), respectively. The experiments with strain A239 were performed twice with six mice per group; one experiment was performed with ATCC strain 90030 with four mice per group.

To evaluate antibiotic-associated changes in the stool microflora, denaturing gradient gel electrophoresis (DGGE) of PCR-amplified bacterial rRNA genes was performed as previously described (12) on stool samples obtained from three mice from the above treatment groups. The similarities between the DGGE profiles were assessed by calculating similarity indices based on the Dice similarity coefficient and the unweighted pair group method using arithmetic averages for clustering, and corresponding dendrograms showing relationships among the DGGE profiles were constructed. The clindamycin, aztreonam, and cefepime groups were excluded because we have previously published data demonstrating the effect of these agents on the DGGE patterns of mice (13); clindamycin causes significant disruption of the DGGE patterns, whereas aztreonam and cefepime do not (13).

Data analyses were performed with Stata (College Station, Tex.) software (version 6.0). A one-way analysis of variance was performed to compare the groups, with P values adjusted for multiple comparisons using the Scheffe correction. Student's t test was used to compare DGGE similarity indices among groups.

Figure 1 shows the stool densities of the four C. glabrata strains in mice treated with piperacillin-tazobactam or normal saline. The density of colonization was significantly higher in the piperacillin-tazobactam-treated mice than in the saline controls (P < 0.01 for each strain). Figure 2A shows the effect of antibiotic treatment on establishment of colonization by strain A239. In comparison to controls, the ceftriaxone, piperacillin-tazobactam, and metronidazole groups developed increased density of colonization (P ≤ 0.02), whereas the cefepime, levofloxacin, and aztreonam groups did not (P ≥ 0.15). Higher human equivalent doses of cefepime, levofloxacin, and aztreonam calculated by the technique of Freireich et al. (3) also did not promote significant overgrowth of C. glabrata A239, although there was a trend toward higher densities in the aztreonam and cefepime groups. Mice in the ceftriaxone, piperacillin-tazobactam, cefepime, levofloxacin, and aztreonam groups had undetectable levels (limit of detection, ∼2.5 log10 CFU/g) of total aerobic and facultative gram-negative bacilli (P < 0.01 for each group in comparison to controls), whereas the density of these organisms in the metronidazole group (mean ± standard deviation [SD], 5.4 ± 1.2 log10 CFU/g) did not differ from that for the controls (mean ± SD, 4.9 ± 0.61 log10 CFU/g) (P = 0.6). Figure 2B shows the effect of antibiotic treatment on establishment of colonization by ATCC strain 90030. In comparison to controls, the ceftriaxone, piperacillin-tazobactam, and clindamycin groups developed increased density of colonization (P < 0.0001), whereas the cefepime, levofloxacin, and aztreonam groups did not (P ≥ 0.89).

Figure 3 shows a representative DGGE gel. Marked alterations were noted in the DGGE patterns of the ceftriaxone-, piperacillin-tazobactam-, and metronidazole-treated mice (mean similarity indices in comparison to controls, 17, 5, and 31%, respectively), whereas the levofloxacin-treated mice had only minor changes (mean similarity index in comparison to controls, 67%) (P < 0.0001). Preliminary analyses in our laboratory suggest that the bands in the DGGE pattern of the control mice predominantly represent anaerobic bacteria.

In summary, we found that antibiotics that inhibited intestinal anaerobes based on DGGE analysis (piperacillin-tazobactam, ceftriaxone, metronidazole, and clindamycin) promoted persistent high-density colonization with C. glabrata. Antibiotics that inhibited facultative gram-negative bacilli but not anaerobes (levofloxacin, cefepime, and aztreonam) did not promote C. glabrata colonization; other investigators have demonstrated that such agents either do not promote intestinal colonization with C. albicans or do so only to a modest degree (4, 5, 7, 8, 10, 11). Antibiotic-associated overgrowth of Candida species in the gastrointestinal tract may have important clinical implications. Tomoda et al. (14) found that leukemia patients with ≥105Candida CFU/g of feces were significantly more likely to develop Candida infections than patients with lower densities of colonization. Louie et al. (6) demonstrated that treatment of febrile neutropenic patients with moxalactam (a potent antianaerobic antibiotic), but not with aztreonam, resulted in inhibition of intestinal anaerobes and an increased frequency of isolation of Candida from clinical cultures. Further studies are needed to evaluate the effect of antibiotic therapy on intestinal overgrowth of C. glabrata in patients.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Effect of subcutaneous piperacillin-tazobactam administration on the density of stool colonization with four strains of C. glabrata. Mice received subcutaneous piperacillin-tazobactam or normal saline daily from day −2 to day 6 and 108 CFU of the C. glabrata strains on day 0. NS, normal saline; P/T, piperacillin-tazobactam; strain 1, A239; strain 2, A129; strain 3, ATCC 90030; strain 4, MRL 191. Error bars indicate standard errors.

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

Effect of subcutaneous antibiotic administration on the density of stool colonization with C. glabrata strains A239 (A) and ATCC 90030 (B). Mice received subcutaneous antibiotics or normal saline daily from day −2 to day 6 and 106 CFU of C. glabrata on day 0. For strain A239, pooled data from two experiments are shown. Error bars indicate standard errors.

FIG. 3.
  • Open in new tab
  • Download powerpoint
FIG. 3.

DGGE patterns of stool samples obtained from mice on day 3 of treatment with subcutaneous saline (lanes 2 and 3), levofloxacin (lanes 4 and 5), piperacillin-tazobactam (lanes 6 and 7), ceftriaxone (lanes 8 and 9), and metronidazole (lanes 10 and 11). A control pattern (lanes 1 and 12) contained PCR products obtained from strains of Escherichia coli, Fusobacterium nucleatum, Bacteroides thetaiotaomicron, and Bacteroides uniformis.

ACKNOWLEDGMENTS

This work was supported by a grant from Ortho-McNeil Pharmaceuticals and by an Advanced Research Career Development Award from the Department of Veterans Affairs to C.J.D.

FOOTNOTES

    • Received 30 April 2004.
    • Returned for modification 25 June 2004.
    • Accepted 16 September 2004.
  • Copyright © 2005 American Society for Microbiology

REFERENCES

  1. 1.↵
    Cole, G. T., A. A. Halawa, and E. J. Anaissie. 1996. The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin. Infect. Dis.22(Suppl. 2):S73-S88.
    OpenUrlPubMed
  2. 2.↵
    Donskey, C. J., J. A. Hanrahan, R. A. Hutton, and L. B. Rice. 1999. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J. Infect. Dis.180:384-390.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    Freireich, E., E. Gehan, D. Rall, L. Schmidt, and H. Skipper. 1966. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man. Cancer Chemother. Rep.50:219-244.
    OpenUrlPubMed
  4. 4.↵
    Kennedy, M. J., and P. A. Volz. 1985. Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. Sabouraudia J. Med. Vet. Mycol.23:265-273.
    OpenUrl
  5. 5.↵
    Kennedy, M. J. 1989. Regulation of Candida albicans populations in the gastrointestinal tract: mechanisms and significance in GI and systemic candidiasis. Curr. Top. Med. Mycol.3:315-402.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Louie, T. J. 1985. Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient. Rev. Infect. Dis.7(Suppl. 4):S747-S761.
    OpenUrl
  7. 7.↵
    Maraki, S., E. Barbounakis, I. Chatzinikolaou, N. Anatoliotakis, M. Plataki, Y. Tselentis, and G. Samonis. 1998. Effects of cefepime, cefixime and ceftibuten on murine gut colonization by Candida albicans.. Chemotherapy44:405-408.
    OpenUrlCrossRefPubMed
  8. 8.↵
    Mavromanolakis, E., S. Maraki, A. Cranidis, Y. Tselentis, D. P. Kontoyiannis, and G. Samonis. 2001. The impact of norfloxacin, ciprofloxacin and ofloxacin on human gut colonization by Candida albicans. Scand. J. Infect. Dis.33:477-478.
    OpenUrlCrossRefPubMed
  9. 9.
    Samonis, G., E. J. Anaissie, and G. P. Bodey. 1990. Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice. Antimicrob. Agents Chemother.34:2420-2422.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Samonis, G., A. Gikas, E. J. Anaissie, G. Vrenzos, S. Maraki, Y. Tselentis, and G. P. Bodey. 1993. Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob. Agents Chemother.37:51-53.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Samonis, G., M. Dassiou, and H. Anastassiadou. 1994. Antibiotics affecting gastrointestinal colonization of mice by yeasts. J. Chemother.6:50-52.
    OpenUrlPubMedWeb of Science
  12. 12.↵
    Stiefel, U., N. J. Pultz, J. Harmoinen, P. Koski, K. Lindevall, M. S. Helfand, and C. J. Donskey. 2003. Oral administration of β-lactamase preserves colonization resistance of piperacillin-treated mice. J. Infect. Dis.188:1605-1609.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Stiefel, U., N. J. Pultz, M. S. Helfand, and C. J. Donskey. 2004. Increased susceptibility to establishment of vancomycin-resistant Enterococcus intestinal colonization persists after completion of antianaerobic antibiotic treatment in mice. Infect. Control Hosp. Epidemiol.25:373-379.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    Tomoda, T., Y. Nakano, and T. Kageyama. 1988. Intestinal Candida overgrowth and Candida infection in patients with leukemia: effect of Bifidobacterium administration. Bifidobacteria Microflora7:71-74.
    OpenUrl
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Effect of Parenteral Antibiotic Administration on Establishment of Intestinal Colonization by Candida glabrata in Adult Mice
Nicole J. Pultz, Usha Stiefel, Mahmoud Ghannoum, Marion S. Helfand, Curtis J. Donskey
Antimicrobial Agents and Chemotherapy Dec 2004, 49 (1) 438-440; DOI: 10.1128/AAC.49.1.438-440.2005

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Effect of Parenteral Antibiotic Administration on Establishment of Intestinal Colonization by Candida glabrata in Adult Mice
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effect of Parenteral Antibiotic Administration on Establishment of Intestinal Colonization by Candida glabrata in Adult Mice
Nicole J. Pultz, Usha Stiefel, Mahmoud Ghannoum, Marion S. Helfand, Curtis J. Donskey
Antimicrobial Agents and Chemotherapy Dec 2004, 49 (1) 438-440; DOI: 10.1128/AAC.49.1.438-440.2005
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-Bacterial Agents
Candida glabrata
Intestines

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596